MSGN1
Mesogenin-1
Also known as: MSGN1_HUMAN, pMesogenin1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NI15
- Gene
- MSGN1
- Ensembl
- ENSG00000151379
- Chromosome
- 2
- Canonical length
- 193 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Acrosome,Equatorial segment,Mid piece
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in mesoderm formation and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within segment specification and somitogenesis. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
193 residues, UniProt reviewed canonical sequence.
>A6NI15|MSGN1
1 MDNLRETFLS LEDGLGSSDS PGLLSSWDWK DRAGPFELNQ ASPSQSLSPA PSLESYSSSP
61 CPAVAGLPCE HGGASSGGSE GCSVGGASGL VEVDYNMLAF QPTHLQGGGG PKAQKGTKVR
121 MSVQRRRKAS EREKLRMRTL ADALHTLRNY LPPVYSQRGQ PLTKIQTLKY TIKYIGELTD
181 LLNRGREPRA QSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against MSGN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 1.1 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 1.1 nTPM
- esophagus: 0.2 nTPM
- salivary gland: 0.1 nTPM
- testis: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- sertoli cells: 1.1 nCPM
- esophageal basal cells: 0.8 nCPM
- choroid plexus epithelial cells: 0.6 nCPM
- early spermatids: 0.5 nCPM
- breast lactating cells: 0.4 nCPM
- epididymal efferent duct ciliated cells: 0.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 1.3 nTPM
- cerebral cortex: 0.3 nTPM
- basal ganglia: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- mesoderm formation
- regulation of transcription by RNA polymerase II
- segment specification
- somitogenesis
Molecular functions
- chromatin binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MSGN1 as an antibody target. Whether an autoantibody or antibody against MSGN1 could matter depends on whether native MSGN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MSGN1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MSGN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...